Fundz

Scancell secures $39.1 million in financing through a Private Placement alongside its merger with Neuphoria Therapeutics. The combined entity plans to trade as 'Scancell' on Nasdaq under symbol 'SCLT'.

PRIVATEJul 23, 2026

Amount Raised

$39.1 Million

Round Type

Post-IPO Equity

BiotechnologyHealth CareMedicalTherapeutics

Description

Scancell Holdings plc announces a merger agreement with Neuphoria Therapeutics and secures $39.1 million through a Private Placement. The financing is part of a larger plan to raise up to $89 million through various offerings. The merger is aimed at enhancing Scancell's market position and supporting its leading asset, iSCIB1+. Completion is subject to shareholder approval.

Quick answer

Scancell Holdings PLC raised $39.1 Million in a Post-IPO Equity round, dated July 23, 2026.

How much did Scancell Holdings PLC raise?
Scancell Holdings PLC raised $39.1 Million in a Post-IPO Equity round on July 23, 2026.
What does Scancell Holdings PLC do?
Scancell Holdings PLC is a company focused on developing innovative cancer vaccines and immunotherapies.

Source: Fundz verified event record.

Who else raised in Medical and Therapeutics around the same time

Companies in the same sectors as Scancell Holdings PLC that raised within 45 days of this round, from Fundz verified event records.

  • N-Power Medicine raised $32M (Series B) on September 1, 2026.
  • Adjuvia Therapeutics raised $8M (Seed) on July 29, 2026.
  • Georgiamune raised $93M on July 16, 2026.
  • Imagion Biosystems raised $2.8M (Post-IPO Equity) on June 25, 2026.
  • Racura Oncology raised $34M (Funding Round) on June 17, 2026.
  • Gate2Brain raised $8.1M on June 16, 2026.

Who to call at Scancell Holdings PLC, and when

A new round usually means Scancell Holdings PLC is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Scancell Holdings PLC raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Scancell Holdings PLC, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Scancell Holdings PLC. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Scancell Holdings PLC

About

Scancell Holdings PLC is a company focused on developing innovative cancer vaccines and immunotherapies. The company aims to bring groundbreaking treatments to cancer patients, with a strong focus on clinical advancements and scientific leadership.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Scancell Holdings PLC raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Scancell Holdings PLC's next move

See what Strategic adds

Scancell Holdings PLC raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.